Register to chat with like-minded investors on our interactive forums.

Get Started

RARE Ultragenyx Pharmaceutical Inc

59.065

0.315 (0.54%)

Last Updated: 09:38:33

Delayed by 15 minutes

Ultragenyx's UX053 gets FDA and EC Orphan Drug status'

To read the full story on Seeking Alpha, click here.

Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Ultragenyx Pharmaceutical Charts.

Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Ultragenyx Pharmaceutical Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Ultragenyx Pharmaceutical Inc News

More Ultragenyx Pharmaceutical Inc News Articles

Lehman Brothers Financial (CE)

Lightwave Logic

Kraig Biocraft Laborator... (QB)

Revance Therapeutics

Rennova Health (CE)

Impact Fusion (PK)

Bioelectronics (PK)

Clean Vision (QB)

Northwest Biotherapeutics (QB)

Elite Pharmaceuticals (QB)

Voip Pal Com (QB)

Asia Broadband (PK)

Anavex Life Sciences

Delayed Upgrade Clock